Qin Yang is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Plaza Dr
Irvine, CA 926975400
Telephone
949-824-8600Registry record last updated 14 Aug 2019.
Clinical trials
- SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
Sponsor: Aptitude Medical Systems
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20241 payment
- Dexcom, Inc.Program year20241 payment
- BETA BIONICS, INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.7%Biguanide (metformin)11.7%Metformin Hcl53%Metformin Hcl Er48%Part D<11 patientsInsulin Analog10.9%Lantus Solostar64%Tresiba Flextouch U-10036%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
26.4%l-Thyroxine18.3%Levothyroxine Sodium84%Synthroid16%Part D<11 patientsRecombinant Human Growth Hormone6%Genotropin100%Part D<11 patients+ 1 more class in this area
Cardiovascular
22.2%Statin15.9%Atorvastatin Calcium81%Rosuvastatin Calcium19%Part D<11 patientsCalcium channel blocker3.6%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Alternative polyadenylation as a novel mechanism for diabetes
University of California-Irvine
FY2026$599,337R01DK136940 - Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism
University of California-Irvine
FY2026$497,505R01DK121146 - Alternative polyadenylation as a novel mechanism for diabetes
University of California-Irvine
FY2025$845,042R01DK136940
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”